These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25503598)

  • 1. Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza).
    Katz NP; Mou J; Paillard FC; Turnbull B; Trudeau J; Stoker M
    Clin J Pain; 2015 Oct; 31(10):859-66. PubMed ID: 25503598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.
    Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
    Clin J Pain; 2014 Apr; 30(4):286-94. PubMed ID: 23765045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database.
    Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
    Pain; 2013 Sep; 154(9):1632-1639. PubMed ID: 23707278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
    Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
    Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capsaicin 8% topical patch (Qutenza)--a review of the evidence.
    Jones VM; Moore KA; Peterson DM
    J Pain Palliat Care Pharmacother; 2011; 25(1):32-41. PubMed ID: 21426216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia.
    Martini CH; Yassen A; Krebs-Brown A; Passier P; Stoker M; Olofsen E; Dahan A
    Eur J Pain; 2013 Nov; 17(10):1491-501. PubMed ID: 23650124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia.
    Webster LR; Tark M; Rauck R; Tobias JK; Vanhove GF
    BMC Neurol; 2010 Oct; 10():92. PubMed ID: 20937130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effective pain relief of post-herpetic neuralgia with capsaicin patch].
    Andersen HH; Sand C; Elberling J
    Ugeskr Laeger; 2016 Feb; 178(5):V10150846. PubMed ID: 26857302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia.
    Wallace M; Pappagallo M
    Expert Rev Neurother; 2011 Jan; 11(1):15-27. PubMed ID: 21158551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttraumatic and postsurgical neuropathic pain responsive to treatment with capsaicin 8% topical patch.
    Zis P; Apsokardos A; Isaia C; Sykioti P; Vadalouca A
    Pain Physician; 2014; 17(2):E213-8. PubMed ID: 24658488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain.
    Burness CB; McCormack PL
    Drugs; 2016 Jan; 76(1):123-34. PubMed ID: 26666418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
    Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
    BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis.
    Wagner T; Poole C; Roth-Daniek A
    Pain Med; 2013 Aug; 14(8):1202-11. PubMed ID: 23710678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
    Irving GA; Backonja MM; Dunteman E; Blonsky ER; Vanhove GF; Lu SP; Tobias J;
    Pain Med; 2011 Jan; 12(1):99-109. PubMed ID: 21087403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy Analysis of Capsaicin 8% Patch in Neuropathic Peripheral Pain Treatment.
    Tenreiro Pinto J; Pereira FC; Loureiro MC; Gama R; Fernandes HL
    Pharmacology; 2018; 101(5-6):290-297. PubMed ID: 29587275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
    Armstrong EP; Malone DC; McCarberg B; Panarites CJ; Pham SV
    Curr Med Res Opin; 2011 May; 27(5):939-50. PubMed ID: 21375358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension.
    Backonja MM; Malan TP; Vanhove GF; Tobias JK;
    Pain Med; 2010 Apr; 11(4):600-8. PubMed ID: 20113411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia.
    Irving G; Backonja M; Rauck R; Webster LR; Tobias JK; Vanhove GF
    Clin J Pain; 2012 Feb; 28(2):101-7. PubMed ID: 21753727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal topical capsaicin in post-herpetic neuralgia: a safety pilot study.
    Teixeira MJ; Menezes LM; Silva V; Galhardoni R; Sasson J; Okada M; Duarte KP; Yeng LT; Andrade DC
    Arq Neuropsiquiatr; 2015 Mar; 73(3):237-40. PubMed ID: 25807130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsaicin patch (Qutenza) for postherpetic neuralgia.
    Med Lett Drugs Ther; 2011 May; 53(1365):42-3. PubMed ID: 21617594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.